Drug Trial Radar · NCT04612972
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru
Last checked: Nov 20, 2026Latest source record: May 1, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12,000
Actual
Start
Sep 9, 2020
Primary completion
Feb 19, 2021
Study completion Apr 3, 2023
Sponsor
- Lead sponsor
- Universidad Peruana Cayetano HerediaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National University of San Marcos, Peru
- First posted
- Nov 3, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, double blind, parallel placebo controlled, phase 3 clinical trial to evaluate the protective efficacy, safety and immunogenicity of inactivated SARS-CoV-2 vaccines in healthy population 18 years old and above.
Conditions
- COVID-19
Interventions
Inactivated SARS CoV 2 vaccine (Vero cell) Wuhan/Beijing/PlaceboBiological
This clinical trial is conducted in randomized, blind, placebo controlled design Total sample size is 12 000, which are randomly allocated into investigational vaccine 1, investigational vaccine 2 and placebo control group.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of confirmed Covid-19 cases in the two vaccine groups and the placebo group.Time frame: One year beginning on day 14 after the second dose of immunization
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Av. Honorio Delgado 430, Urb. Ingeniería
San Martín de Porres, Lima region, Peru
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.